Fresenius Medical Care AG (FRA:FME)
Germany · Delayed Price · Currency is EUR | Market Cap | 11.04B |
| Revenue (ttm) | 19.64B |
| Net Income (ttm) | 718.19M |
| Shares Out | n/a |
| EPS (ttm) | 2.44 |
| PE Ratio | 15.37 |
| Forward PE | 11.29 |
| Dividend | 1.44 (3.59%) |
| Ex-Dividend Date | May 23, 2025 |
| Volume | 865 |
| Average Volume | 440 |
| Open | 39.05 |
| Previous Close | 38.90 |
| Day's Range | 39.05 - 39.85 |
| 52-Week Range | 38.64 - 54.00 |
| Beta | n/a |
| RSI | 43.33 |
| Earnings Date | Feb 24, 2026 |
About Fresenius Medical Care AG
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospital... [Read more]
Financial Performance
In 2024, Fresenius Medical Care AG's revenue was 19.34 billion, a decrease of -0.61% compared to the previous year's 19.45 billion. Earnings were 537.91 million, an increase of 7.80%.
Financial StatementsNews
Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned
The second tranche of the share buyback is expected to be executed by May 8, 2026 The share buyback program with a total volume of EUR 1 billion is expected to be completed in less than a year, signif...
DAX Up Marginally; Fresenius Medical Care Rises On Buy-back Announcement
(RTTNews) - German stocks gained marginal ground in positive territory Friday morning. Data showing an unexpected growth in the nation's industrial output in the month of November aided sentiment. Inv...
EQS-AFR: Fresenius Medical Care AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements
EQS Preliminary announcement financial reports: Fresenius Medical Care AG / Preliminary announcement on the disclosure of financial statements Fresenius Medical Care AG: Preliminary announcement of th...
EQS-AFR: Fresenius Medical Care AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQS Preliminary announcement financial reports: Fresenius Medical Care AG / Preliminary announcement on the disclosure of financial statements Fresenius Medical Care AG: Preliminary announcement of th...
Fresenius Medical Care Continues EUR 1 Bln Share Buyback With Second Tranche
(RTTNews) - Fresenius Medical Care AG (FMS, FME.DE), on Friday announced the continuation of its share buyback programme with a second tranche, following the early completion of the first tranche on D...
EQS-Adhoc: Fresenius Medical Care AG : Fresenius Medical Care AG is continuing its share buyback program in an accelerated manner
EQS-Ad-hoc: Fresenius Medical Care AG / Key word(s): Share Buyback Fresenius Medical Care AG : Fresenius Medical Care AG is continuing its share buyback program in an accelerated manner 09-Jan-2026 / ...
Do Options Traders Know Something About FMS Stock We Don't?
Investors need to pay close attention to Fresenius Medical Care stock based on the movements in the options market lately.
EQS-CMS: Fresenius Medical Care AG : Release of a capital market information
EQS Post-admission Duties announcement: Fresenius Medical Care AG / Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014 Fresenius Medical Care AG : Release of a capital marke...
EQS-PVR: Fresenius Medical Care AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: Fresenius Medical Care AG Fresenius Medical Care AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Eu...
Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now
FMS's acquisitions, partnerships and global reach fuel growth, even as rising costs and optimization efforts weigh on near-term performance.
Fresenius Medical Care ernennt neuen Chief Medical Officer
DJ Fresenius Medical Care ernennt neuen Chief Medical Officer DOW JONES--Fresenius Medical Care bekommt einen neuen Chief Medical Officer. Wie der Dialysespezialist mitteilte, hat er Charles Hugh-...
Fresenius Medical (FMS) Appoints New Chief Medical Officer for 2026
Fresenius Medical (FMS) Appoints New Chief Medical Officer for 2026
Fresenius Medical Names Charles Hugh-Jones Global CMO
(RTTNews) - Fresenius Medical Care AG (FMS, FME.DE), a provider of dialysis products and services, on Wednesday announced that it has appointed Charles Hugh-Jones as Global Chief Medical Officer on Ja...
Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board
Effective January 1, 2026, Charles Hugh-Jones will join the Management Board as Global Chief Medical Officer As part of a planned transition Franklin W. Maddux will retire by year end BAD HOMBURG, Ger...
EQS-PVR: Fresenius Medical Care AG: Publication of acquisition or disposal in respect of own shares according Sec. 40 para. 1 sent. 2 WpHG
EQS Voting Rights Announcement: Fresenius Medical Care AG Fresenius Medical Care AG: Publication of acquisition or disposal in respect of own shares according Sec. 40 para. 1 sent. 2 WpHG 03.12.2025 /...
Fresenius Medical Care: 'Buy' Again Following A Peak In May
Discover why Fresenius Medical Care (FMS) is a buy - strong growth, dividend safety, and new product rollout promise double-digit EPS.
Commerzbank AG (London Branch) - Pre Stabilisation - Fresenius Medical Care AG EUR500mil 5 year
Commerzbank AG (London Branch) - Pre Stabilisation - Fresenius Medical Care AG EUR500mil 5 year PR Newswire LONDON, United Kingdom, November 17 Pre-Stabilisation Notice November 17, 2025 Not for d...
EQS-CMS: Fresenius Medical Care AG : Release of a capital market information
EQS Post-admission Duties announcement: Fresenius Medical Care AG / Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014 Fresenius Medical Care AG : Release of a capital marke...
Fresenius Medical Care AG (FMS) Q3 2025 Earnings Call Transcript
Fresenius Medical Care AG (FMS) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ...
Fresenius Medical Care AG (FMS) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Initiatives Propel Performance
Q3 2025 Fresenius Medical Care AG Earnings Call Transcript
Q3 2025 Fresenius Medical Care AG Earnings Call Transcript
EQS-CMS: Fresenius Medical Care AG : Release according to Article 50 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Post-admission Duties announcement: Fresenius Medical Care AG / Third country release according to Article 50 Para. 1, No. 2 of the WpHG [the German Securities Trading Act] Fresenius Medical Care ...
Fresenius Medical Care is Now Oversold (FMS)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a tec...
Fresenius Medical Care (FMS) Shares Cross Below 200 DMA
In trading on Tuesday, shares of Fresenius Medical Care (Symbol: FMS) crossed below their 200 day moving average of $25.80, changing hands as low as $23.68 per share. Fresenius Medical Care shares are...
Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025
Strong organic revenue growth1 of 10% driven by all operating segments Positive U.S. same market treatment growth of 0.1 % in line with expectations Accelerated operating income2 growth of 28% at cons...